Avalo Therapeutics
AVTX
AVTX
18 hedge funds and large institutions have $1.9M invested in Avalo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
18
Holders Change
+6
Holders Change %
+50%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$46.2K |
2 |
N
2
Natixis
Paris,
France
|
$54.6K |
3 |
FIA
3
FNY Investment Advisers
New York
|
$0 |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$35.7K |
5 |
5
Morgan Stanley
New York
|
$848 |